SHARE

GenesisCare to open seventh UK SACT centre in Tunbridge Wells 

The independent cancer care provider has announced plans to open a Systemic Anti-Cancer Therapy centre in Royal Tunbridge Wells, UK, in autumn 2026. The facility will deliver chemotherapy, immunotherapy and cellular therapies in a purpose-built setting.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.